Healthcare affordability has been a top issue heading into the midterms, with 62% of adults worried about affording medical care for themselves and their families, according to data from Kaiser Family Foundation.
On the campaign trail, candidates from both parties have promised relief. But come January, when the newly elected winners are sworn in, they’ll discover firsthand how much harder it is to enact change than to talk about it.
Why Popular Healthcare Solutions Fall Short
Progressive Democrats championed Medicare for All. Michigan Senate candidate Abdul El-Sayed advocated replacing private insurance with government-financed coverage. KFF polling found two-thirds of American adults support the concept.
But expanding coverage through Medicare for All isn’t the same as making medical care more efficient or effective.
Currently, Congress authorizes the Centers for Medicare and Medicaid Services to set Medicare reimbursement rates without negotiating with doctors or hospitals. Congress also limits how quickly those rates can rise. As a result, Medicare payments now average roughly 10% below hospitals’ reported expenses. To compensate for these federal underpayments, hospitals charge private insurers an average of 254% of Medicare rates, according to RAND.
If Medicare paid for all Americans' medical care at Medicare rates, hospital revenue would plummet while demand for medical services would remain unchanged. With 43% of hospitals already operating at a loss, these facilities would have to cut services or close.
Republicans generally prefer less government control, but several, including Senator Susan Collins (Maine), have also called for price caps. Recently, she championed bipartisan legislation that would limit privately insured patients’ monthly insulin costs to $35.
Price and spending caps have been tried before, with mixed results. Neither has addressed the underlying problems in how medical care is delivered. When reimbursement rates were capped in the past, providers increased service volume to maintain income. And when overall healthcare spending is capped without improving efficiency, backlogs develop and patients face longer waits for nonemergency care, as seen in Canada and the UK.
Two Ways To Improve The Economics
Annual U.S. healthcare spending now totals $5.7 trillion, more than the entire economy of Germany or Japan. In 2026, employer-sponsored family insurance premiums rose 5%, while inflation was 2.7% and wages grew 3.7%.
For a challenge of this magnitude, no simple, short-term solutions exist. Meaningful progress will require congressional action, with two promising paths forward. One would improve Americans’ health to reduce expensive, avoidable complications. The other would increase competition, encouraging insurers and providers to deliver better care at lower cost.
1. Reducing Costs By Improving Health
The biggest contributors to life-threatening, expensive inpatient care are complications from chronic diseases and obesity-related illnesses. Together they account for millions of heart attacks, strokes, cancers, and kidney failures each year.
Preventing chronic diseases and better controlling them when they develop would reduce the need for costly treatment by hundreds of billions of dollars. Two recent advances offer significant opportunities.
Affordable GLP-1 medications
After decades of disappointing weight-loss efforts, newer medications have produced impressive results. In major trials, semaglutide and tirzepatide produced average weight losses of approximately 15% to 21%, depending on the specific medication and dose.
But GLP-1 prices limit access. To make these medications more affordable for the 40% of Americans who are obese, Congress could amend the Food, Drug, and Cosmetic Act to allow lower-cost compounded versions when FDA-approved drugs are unaffordable. The change would extend certain drug-shortage exceptions to medications that are financially inaccessible, even when supplies are adequate.
Generative AI for chronic disease control
Prevention is paramount, but tens of millions of Americans will still develop chronic conditions. Today, fewer than half of Americans with hypertension or diabetes achieve recommended blood pressure or blood glucose targets, according to CDC data. More frequent monitoring and medication adjustments would help improve control.
A patient-facing GenAI system connected to home blood-pressure or blood-glucose monitors could track the data, identify inadequate responses to treatment and alert clinicians. Physicians could then adjust medications months before the next scheduled appointment, improving disease control and reducing the risk of costly complications, including heart attacks, strokes and kidney failure.
To provide this type of clinical support to all Americans, Congress and the Trump administration should launch an Operation Warp Speed-style initiative involving NIH, FDA, CMS, AI developers and clinicians. Together, they would build, validate, deploy, and monitor these affordable patient-facing tools for safety, reliability, and clinical effectiveness.
2. Lowering Costs Through Greater Competition And Improved Care
About 166 million Americans receive health insurance through employers, often with limited plan choices. The government can expand competition through an existing federal program.
Established in 2020, Individual Coverage Health Reimbursement Arrangements (ICHRAs) let employers fund coverage while workers choose the best plans for their families, including those on ACA exchanges. This option would give employers greater cost predictability and let them avoid selecting insurance plans for their employees.
Congress could strengthen the program with two changes.
First, give employees more options. Suppose a family receives a $20,000 employer allowance and chooses a qualifying $15,000 plan. New legislation could allow the remaining $5,000, subject to applicable limits, to go into an employee-owned, tax-advantaged Health Savings Account.
Second, require independently verified information on premiums, out-of-pocket costs, clinical outcomes, and access, so families can compare overall value between plans. Bringing more working Americans into individual insurance markets would attract more insurers and increase competition. Regional insurers could partner with local hospitals or capitated physician groups to offer affordable coverage built around coordinated care and better outcomes.
Greater competition would drive insurers to negotiate lower prices and reward efficient providers. Results would vary by market, but nationwide, the incentives would encourage more innovation and better value.
Both programs, one to improve health and one to increase competition, would lower medical costs. When the campaign ends, Congress must move beyond its promises and take steps to make American healthcare more affordable.
Robert Pearl, the author of “ChatGPT, MD,” teaches at both the Stanford University School of Medicine and the Stanford Graduate School of Business. He is a former CEO of The Permanente Medical Group.



















